Market Overview:
The global paliperidone palmitate reagent market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of mental disorders, rising demand for better and advanced diagnostic tests, and growing investments by key players in R&D activities. Based on type, the global paliperidone palmitate reagent market can be segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The min purity less than 98% segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of xx% during the forecast period. Based on application, the global paliperidone palmitate reagent market can be divided into research and medical applications. The research application segment is expected to account for a larger share of the global market in 2018.
Product Definition:
Paliperidone palmitate reagent is a synthetic, enantiomerically pure drug used for the treatment of schizophrenia. It is a dopamine D2 and serotonin 5-HT2A receptor antagonist.
Min Purity Less Than 98%:
Paliperidone palmitate is a long-acting injectable drug used for the treatment of Alzheimer's disease. It was approved by the U.S. FDA in September 2003 and later on by EU in October 2004 as an orphan medicinal product for the treatment of dementia associated with Alzheimer’s disease (AD). In Europe, it has been prescribed to more than 50,000 patients since its approval until today.
Min Purity 98%-99%:
Min Purity 98%-99% is a special type of purified palmitate that contains almost the same amount of active ingredient as compared to pure palmitate but with very low impurities. It has 99% purity and it's commercially available in pellet form which can be easily dissolved in solvents like DMSO or water for injection purposes.
Application Insights:
Research application dominated the global paliperidone palmitate reagent market in 2017, accounting for a share of over 60.0% by revenue. The product is widely used in research applications including schizophrenia and bipolar disorder due to its lipophilicity and solubility which make it suitable for use in micellar solutions. Furthermore, the product exhibits high stability towards oxidation, making it an ideal compound for use in antioxidant studies as well as peroxidation studies related to free radicals and antioxidants.
Medical application is expected to witness the fastest growth over the forecast period owing to increasing incidences of major mental disorders such as Alzheimer¢â‚¬â„¢s disease, Parkinson¢â‚¬â„¢s disease etc., across various regions globally coupled with growing awareness about effective treatment options available for these diseases.
Regional Analysis:
North America accounted for the largest share of global paliperidone palmitate reagent market in 2017. The growth is attributed to the increasing R&D activities and high adoption rate of new pharmaceuticals in this region. Moreover, growing target disease population and rising healthcare expenditure are expected to drive regional demand over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rapid economic development coupled with improving healthcare infrastructure in emerging countries such as China, India, South Korea & Japan. Furthermore, increasing prevalence of chronic diseases such as Parkinson’s disease (PD) has led to an increase in research efforts by various organizations towards developing novel therapies for treating PD patients which will further boost product demand over the coming years.
Growth Factors:
- Increasing demand for novel antipsychotic drugs: The global Paliperidone Palmitate Reagent market is expected to grow at a CAGR of XX% during the forecast period owing to the increasing demand for novel antipsychotic drugs. This is mainly because of the growing prevalence of mental disorders, such as schizophrenia and bipolar disorder, across the globe.
- Rising geriatric population: The geriatric population is more susceptible to mental disorders and is therefore likely to drive the growth of the Paliperidone Palmitate Reagent market during the forecast period.
- Growing awareness about mental health: There has been a growing awareness about mental health in recent years, which is likely to boost demand for antipsychotic drugs in turn driving growth ofthePaliperidone Palmitate Reagent market duringtheforecastperiod.
Scope Of The Report
Report Attributes
Report Details
Report Title
Paliperidone Palmitate Reagent Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Santa Cruz Biotechnology, LGC, Biosynth Carbosynth, BOC Sciences, Selleck Chemicals, Shimadzu, AA Blocks, CSNpharm, Clearsynth, InvivoChem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Paliperidone Palmitate Reagent Market Report Segments:
The global Paliperidone Palmitate Reagent market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Santa Cruz Biotechnology
- LGC
- Biosynth Carbosynth
- BOC Sciences
- Selleck Chemicals
- Shimadzu
- AA Blocks
- CSNpharm
- Clearsynth
- InvivoChem
Highlights of The Paliperidone Palmitate Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Paliperidone Palmitate Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Paliperidone palmitate is a medication used to treat schizophrenia and bipolar disorder. It is also used to treat agitation in Alzheimer's disease patients. Paliperidone palmitate reagent is a colorless liquid that contains the active ingredient paliperidone.
Some of the key players operating in the paliperidone palmitate reagent market are Santa Cruz Biotechnology, LGC, Biosynth Carbosynth, BOC Sciences, Selleck Chemicals, Shimadzu, AA Blocks, CSNpharm, Clearsynth, InvivoChem.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Paliperidone Palmitate Reagent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Paliperidone Palmitate Reagent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Paliperidone Palmitate Reagent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Paliperidone Palmitate Reagent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Paliperidone Palmitate Reagent Market Size & Forecast, 2020-2028
4.5.1 Paliperidone Palmitate Reagent Market Size and Y-o-Y Growth
4.5.2 Paliperidone Palmitate Reagent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Paliperidone Palmitate Reagent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Paliperidone Palmitate Reagent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Paliperidone Palmitate Reagent Market: Competitive Dashboard
14.2 Global Paliperidone Palmitate Reagent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Santa Cruz Biotechnology
14.3.2 LGC
14.3.3 Biosynth Carbosynth
14.3.4 BOC Sciences
14.3.5 Selleck Chemicals
14.3.6 Shimadzu
14.3.7 AA Blocks
14.3.8 CSNpharm
14.3.9 Clearsynth
14.3.10 InvivoChem
